摘要
目的分析2型糖尿病患者并发上消化道出血急性期的临床治疗措施及效果。方法选取2020年6月—2021年9月乌鲁木齐市米东区人民医院治疗的70例急性上消化道出血的2型糖尿病患者为研究对象,分为常规组(n=35,常规治疗)和干预组(n=35,甘精胰岛素治疗)。对比两组的临床治疗效果。结果干预组便潜血转阴时间、住院时间、低血糖发生率与再出血发生率均低于常规组,差异有统计学意义(P<0.05)。干预组空腹血糖值、胰岛素使用情况明显优于常规组,差异有统计学意义(P<0.05)。治疗后,干预组治疗总有效率为97.14%高于常规组的80.00%,差异有统计学意义(P<0.05)。结论2型糖尿病患者发生急性上消化道出血给予甘精胰岛素治疗效果显著,可有效控制血糖,防止患者发生再出血情况,并能缩短患者住院时间。
Objective To analyze the clinical measures and effects of acute upper gastrointestinal bleeding in type 2 diabetes patients.Methods 70 cases of type 2 diabetes patients with acute upper gastrointestinal bleeding treated in Midong People's Hospital of Urumqi City from June 2020 to September 2021 were selected as the research objects,and divided into conventional group(n=35,conventional treatment)and intervention group(n=35,insulin glygine treatment).The clinical therapeutic effect of the two groups was compared.Results The duration of fecal occult blood turning negative,length of hospital stay,incidence of hypoglycemia and rebleeding in the intervention group were lower than those in the conventional group,and the differences were statistically significant(P<0.05).Fasting blood glucose and insulin use in the intervention group were significantly better than those in the conventional group,and the difference was statistically significant(P<0.05).After treatment,the total effective rate of the intervention group was 97.14% higher than that of the conventional group(80.00%),and the difference was statistically significant(P<0.05).Conclusion In patients with type 2 diabetes mellitus with acute upper gastrointestinal bleeding,insulin glargine treatment has significant effects,which can effectively control blood sugar,prevent patients from rebleeding,and shorten the length of hospital stay.
作者
周琳
朱胜斌
窦永江
ZHOU Lin;ZHU Shengbin;DOU Yongjiang(Department of Emergency Medicine,Midong District People's Hospital,Urumqi,Xinjiang Uygur Autonomous Region,831400 China)
出处
《糖尿病新世界》
2023年第8期39-42,共4页
Diabetes New World Magazine
关键词
急性上消化道出血
2型糖尿病
甘精胰岛素
临床疗效
Acute upper gastrointestinal bleeding
Type 2 diabetes mellitus
Glargine insulin
Clinical efficacy
